Kbc Group Nv Crispr Therapeutics Ag Transaction History

Kbc Group Nv

$33.1 Billion
Q3 2024

A detailed history of Kbc Group Nv transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Kbc Group Nv holds 2,818 shares of CRSP stock, worth $145,465. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,818

Previous 1,958 43.92%

Holding current value

$145,465

Previous $106,000 24.53%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$44.62 - $62.75 $38,373 - $53,965	860 Added 43.92%	2,818 $132,000
Q2 2024 Jul 17, 2024	BUY	$51.17 - $68.18 $17,960 - $23,931	351 Added 21.84%	1,958 $106,000
Q4 2023 Feb 13, 2024	BUY	$38.62 - $72.18 $62,062 - $115,993	1,607 New	1,607 $101,000
Q4 2021 Feb 03, 2022	SELL	$70.09 - $111.29 $42,054 - $66,774	-600 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$79.67 - $173.23 $47,802 - $103,938	-600 Reduced 50.0%	600 $92,000
Q4 2019 Feb 11, 2020	BUY	$36.68 - $73.13 $37,963 - $75,689	1,035 Added 627.27%	1,200 $73,000
Q3 2019 Nov 07, 2019	SELL	$40.99 - $52.56 $42,424 - $54,399	-1,035 Reduced 86.25%	165 $6,000
Q2 2019 Dec 03, 2019	BUY	$35.45 - $48.2 $42,540 - $57,840	1,200 New	1,200 $57,000
Q2 2019 Jul 30, 2019	SELL	$35.45 - $48.2 $42,540 - $57,840	-1,200 Closed	0 $0
Q1 2019 Dec 03, 2019	BUY	$28.02 - $40.87 $33,624 - $49,044	1,200 New	1,200 $43,000
Q1 2019 May 10, 2019	SELL	$28.02 - $40.87 $33,624 - $49,044	-1,200 Closed	0 $0
Q4 2018 Dec 03, 2019	BUY	$22.73 - $42.34 $27,276 - $50,808	1,200 New	1,200 $34,000
Q4 2018 Jan 31, 2019	SELL	$22.73 - $42.34 $27,276 - $50,808	-1,200 Closed	0 $0
Q3 2018 Dec 03, 2019	BUY	$44.35 - $65.71 $53,220 - $78,851	1,200 New	1,200 $53,000
Q3 2018 Nov 14, 2018	SELL	$44.35 - $65.71 $53,220 - $78,851	-1,200 Closed	0 $0
Q2 2018 Dec 03, 2019	BUY	$42.62 - $73.59 $51,144 - $88,308	1,200 New	1,200 $71,000
Q2 2018 Aug 03, 2018	SELL	$42.62 - $73.59 $72,454 - $125,103	-1,700 Closed	0 $0
Q1 2018 Dec 03, 2019	BUY	$23.52 - $58.17 $39,984 - $98,889	1,700 New	1,700 $78,000
Q1 2018 May 09, 2018	SELL	$23.52 - $58.17 $16,464 - $40,719	-700 Closed	0 $0
Q4 2017 Dec 03, 2019	BUY	$16.95 - $23.48 $11,865 - $16,436	700	700 $16,000

Others Institutions Holding CRSP

# of Institutions

503

Shares Held

57M

Call Options Held

1.7M

Put Options Held

1.8M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.03B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account